Clinical trials: Covid-19 Patients
COVID-19 Pandemic
The Effect of Telemonitoring on Anxiety and Quality of Life in Patients in COVID 19 Quarantine
The study was carried out to evaluate the effect of telemonitoring service to be given to patients kept under quarantine during the COVID 19 pandemic on anxiety and quality of life.
- Trial name
- NCT05197582
- Testing
- tele-monitoring
- Where
- Turkey (Türkiye)
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Yuksek Ihtisas University
COVID-19
Evaluating the Immune Response for COVID-19
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The measures in which public health officials quarantine confirmed and isolate symptomatic cases in order to reduce the spread COVID-19 is the common…
- Trial name
- COVIDIMMUNE (NCT04348422)
- Testing
- COVID-19 RT-PCR, COVID-19 Serology, Symptoms questionnare
- Where
- Israel
- Volunteers
- 214 people
- Sponsor
- Assaf-Harofeh Medical Center
COVID-19 Infection
Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)
This is a multicenter, non-interventional, retrospective study using data captured in the EHRs (Electronic Health Records) of the participating hospital sites to determine factors that predict disease prognosis and outcomes in…
- Trial name
- NCT04569851
- Where
- 2 sites in Spain
- Volunteers
- 100,000 people
- Sponsor
- Savana Research
Covid19
Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study
Background: In the midst of the devastating COVID pandemic where there is no specific and effective treatment, traditional therapy may help to ease the patient's suffering.
- Trial name
- NCT04900129
- Testing
- Menthol 0.02%, Methyl salicylate 0.05%, N- Acetyl cysteine 1.2 gm%, and Diclofenac sodium 1gm%
- Where
- Bangladesh
- Volunteers
- 43 people
- Sponsor
- Sher-E-Bangla Medical College
COVID-19
Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients
The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx.
- Trial name
- GARGLES (NCT04410159)
- Testing
- Povidone-Iodine, Essential oils, Tap water
- Where
- Malaysia
- Volunteers
- 20 people
- Sponsor
- Universiti Sains Islam Malaysia
Post-COVID Syndrome
Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients
A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery.
- Trial name
- NCT05715554
- Testing
- Homeopathy
- Where
- 5 sites in India
- Volunteers
- 69 people
- Sponsor
- Innowage Limited
COVID-19
A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients
This is a randomized study to assess safety, pharmacokinetics, immunogenicity, and efficacy of BAT2020 in hospitalized patients infected with COVID-19.
- Trial name
- NCT04432766
- Testing
- BAT2020
- Where
- United States
- Sponsor
- Bio-Thera Solutions
Sars-CoV2
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
To date, no treatment has demonstrated clinical efficacy on COVID 19. However, several therapeutic strategies are being considered and are being evaluated in numerous clinical trials.
- Trial name
- PREAVIS (NCT04522466)
- Testing
- Hydroxychloroquine (HCQ)
- Where
- 4 sites in France
- Volunteers
- 7 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Covid-19, Risk Factor, Mortality
Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Mortality rates of COVID-19 pandemics vary between countries.
- Trial name
- NCT04479137
- Testing
- PCR for COVID-19
- Where
- Turkey (Türkiye)
- Volunteers
- 5,000 people
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
Hyperglycemia, Covid19
Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a world health issue during the last months, affecting mostly countries with a high metabolic risk, like Mexico.
- Trial name
- Covid19DPP4i (NCT04542213)
- Testing
- Linagliptin tablet, Insulin
- Where
- Mexico
- Volunteers
- 70 people
- Sponsor
- Hospital Regional de Alta Especialidad del Bajio
Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome)
Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
The overall objective of the study is to determine the therapeutic effect and tolerance of Tocilizumab combined with Dexamethasone in patients with moderate, severe pneumonia or critical pneumonia associated with Coronavirus…
- Conditions
- Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases, Coronaviridae Infections
- Trial name
- TOCIDEX (NCT04476979)
- Testing
- Tocilizumab, Dexamethasone
- Where
- French Guiana
- Volunteers
- 453 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Breast Cancer, Lung Cancer
To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment
This is a trial of prospective collection of serial blood samples after administration of COVID-19 vaccine in patients with cancer who are receiving active cancer treatment, planned to start therapy with 14 days of consent, or…
- Conditions
- Breast Cancer, Lung Cancer, Melanoma (Skin)
- Trial name
- CANINE (NCT04821570)
- Testing
- COVID-19 Vaccine
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- University of Kansas Medical Center
Cardiovascular Diseases, Delirium
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Patients are part of a family network. When any person in a family becomes critically unwell and requires the assistance of an Intensive Care Unit (ICU), this has an impact on all members of that family.
- Conditions
- Cardiovascular Diseases, Delirium, Critical Illness, Intensive Care Unit Delirium
- Trial name
- VINCI (NCT04538469)
- Testing
- COVID visitation restrictions
- Volunteers
- 1,000 people
- Sponsor
- University of Glasgow
SARS-CoV-2 Infection
Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19
The study RECOVER is a randomized, open-label, multicenter phase II trial, designed to assess the clinical outcome of SARS-CoV-2 disease in high-risk patients (group 1 to group 4) following treatment with anti-SARS-CoV-2…
- Trial name
- RECOVER (NCT05200754)
- Testing
- Convalescent/Vaccine-boosted Plasma (CP/PVP)
- Where
- 16 sites in Germany
- Volunteers
- 174 people
- Sponsor
- Carsten Müller-Tidow
Coronavirus Infection
Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)
COVID-19 is an infection linked to a new coronavirus: SARS-CoV-2, which appeared in Wuhan in China at the end of 2019, and which has since spread around the world, responsible for a new major pandemic, which is upsetting the…
- Trial name
- COVID-PSL (NCT04402905)
- Where
- France
- Volunteers
- 450 people
- Sponsor
- Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Hepatocellular Carcinoma, COVID-19
COVID-19 Infection in Patients With Hepatocellular Carcinoma
Since December 2019, a new disease named COVID-19 linked to a new coronavirus, SARS-CoV2 has emerged in China in the city of Wuhan, Hubei province, spreading very quickly to all 5 continents, and responsible for a pandemic.
- Trial name
- COVID19-CHIEF (NCT04367805)
- Testing
- nasopharyngeal Covid 19 RT-PCR
- Where
- France
- Volunteers
- 23 people
- Sponsor
- Centre Hospitalier Universitaire, Amiens
Covid19
Vaccination for Recovered Inpatients With COVID-19 (VATICO)
In this Phase 4, open-label trial, participants of the ACTIV-3/TICO clinical trial at selected sites who received certain pre-specified blinded investigational agents or placebo as part of that trial, and who have since achieved…
- Trial name
- NCT04969250
- Testing
- Moderna mRNA-1273 COVID-19 vaccine, Pfizer BNT162b2 COVID-19 vaccine
- Where
- 30 sites in United States, Nigeria and 4 more
- Volunteers
- 66 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
SARS-COV2 Infection, COVID-19 Disease
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Effect of Covid-19 disease in clotting factors levels in hospitalized patients
- Conditions
- SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients
- Trial name
- NCT04787510
- Testing
- low molecular weight Heparin as standard of care treatment
- Where
- Greece
- Volunteers
- 50 people
- Sponsor
- University Hospital, Ioannina
Covid19, Type 2 Diabetes
Effect of Pioglitazone on T2DM Patients With COVID-19
Approximately 10-15% of patients infected with COVID-19 develop severe illness characterized by respiratory distress, increased risk of clotting disease, myocardial damage, stroke and mortality.
- Trial name
- PIOQ8 (NCT04604223)
- Testing
- Pioglitazone 45 mg
- Where
- 5 sites in Kuwait, Qatar
- Volunteers
- 1,506 people
- Sponsor
- Dasman Diabetes Institute
COVID 19
Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery
This study aims to evaluate the efficacy and safety of Herbamuno+, a combination of several herbal ingredients, as an adjunct therapy for moderate COVID-19 patients at Wisma Atlet.
- Trial name
- NCT06636760
- Testing
- herbal compound
- Where
- Indonesia
- Volunteers
- 66 people
- Sponsor
- Universitas Indonesia
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.